Leonard, John P.

Genetics and pathogenesis of diffuse large B-cell lymphoma

Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment

Cited by 2,241

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology

Cell death mechanisms and regulationLymphoma Diagnosis and Treatment

Cited by 876

AUGMENT: a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., et al. (2019) · Journal of Clinical Oncology

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 434

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Leonard, J. P., LaCasce, A. S., Smith, M. R., Noy, A., Chirieac, L. R., Rodig, S. J., Yu, J. Q., Vallabhajosula, S., Schoder, H., English, P., et al. (2012) · Blood

Lymphoma Diagnosis and TreatmentAdvanced Breast Cancer Therapies

Cited by 299

Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

Chiron, D., Di Liberto, M., Martin, P., Huang, X., Sharman, J., Blecua, P., Mathew, S., Vijay, P., Eng, K., Ali, S., et al. (2014) · Cancer Discovery

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 273

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

Ruan, J., Martin, P., Shah, B., Schuster, S. J., Smith, S. M., Furman, R. R., Christos, P., Rodriguez, A., Svoboda, J., Lewis, J., et al. (2015) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentMultiple Myeloma Research and Treatments

Cited by 236

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

Cardenas, M. G., Yu, W., Beguelin, W., Teater, M. R., Geng, H., Goldstein, R. L., Oswald, E., Hatzi, K., Yang, S.-N., Cohen, J., et al. (2016) · Journal of Clinical Investigation

Lymphoma Diagnosis and TreatmentComputational Drug Discovery Methods

Cited by 176

Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin's Lymphoma Who Had Previously Responded to I-131 Tositumomab

Kaminski, M. S., Radford, J. A., Gregory, S. A., Leonard, J. P., Knox, S. J., Kroll, S., & Wahl, R. L. (2005) · Journal of Clinical Oncology

Lymphoma Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications

Cited by 95

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

Shadman, M., Li, H., Rimsza, L., Leonard, J. P., Kaminski, M. S., Braziel, R. M., Spier, C. M., Gopal, A. K., Maloney, D. G., Cheson, B. D., et al. (2018) · Journal of Clinical Oncology

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 86

Induction of prolonged early G1arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1

Chiron, D., Martin, P., Di Liberto, M., Huang, X., Ely, S., Lannutti, B. J., Leonard, J. P., Mason, C. E., & Chen-Kiang, S. (2013) · Cell Cycle

PI3K/AKT/mTOR signaling in cancerLymphoma Diagnosis and Treatment

Cited by 71

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib

Yang, C., Lu, P., Lee, F. Y., Chadburn, A., Barrientos, J. C., Leonard, J. P., Ye, F., Zhang, D., Knowles, D. M., & Wang, Y. L. (2008) · Leukemia

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 61

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

Song, Z., Lu, P., Furman, R. R., Leonard, J. P., Martin, P., Tyrell, L., Lee, F. Y., Knowles, D. M., Coleman, M., & Wang, Y. L. (2010) · Clinical Cancer Research

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 59

Pilot Study of Aurora, a Social, Mobile-Phone-Based Emotion Sharing and Recording System

Gay, G., Pollak, J. P., Adams, P., & Leonard, J. P. (2011) · Journal of Diabetes Science and Technology

Innovative Human-Technology InteractionMobile Health and mHealth Applications

Cited by 40

The feasibility, acceptability, and usability of telehealth visits

Sinha Gregory, N., Shukla, A. P., Noel, J. J., Alonso, L. C., Moxley, J., Crawford, A. J., Martin, P., Kumar, S., Leonard, J. P., & Czaja, S. J. (2023) · Frontiers in Medicine

Telemedicine and Telehealth ImplementationHealthcare Systems and Technology

Cited by 33

Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling

Cerchietti, L., Inghirami, G., Kotlov, N., Svekolkin, V., Bagaev, A., Frenkel, F., Revuelta, M. V., Phillip, J. M., Cacciapuoti, M. T., Rutherford, S. C., et al. (2019) · Blood

Lymphoma Diagnosis and TreatmentViral-associated cancers and disorders

Cited by 7